- Visibility 98 Views
- Downloads 28 Downloads
- Permissions
- DOI 10.18231/j.ijmr.2020.014
-
CrossMark
- Citation
Optimisation of reactant concentration in Biosynthesis of Silver nanoparticles using pathogenic bacteria isolated from clinical sources and their characterisation
- Author Details:
-
Valentina Y *
Abstract
Introduction: The all-around attraction towards Silver Nanoparticles (AgNPs) is fairly due to its biocompatibility, so that it can be used in therapeutics and diagnostics. In order, to harvest them with such unique properties, there is this pressing urge to develop a cheaper and an eco-friendly process without the use of toxic chemicals. In lieu of this, this study was taken up to optimise the reactant parameters required to obtain a maximum yield of AgNPs using cell-free culture extract of bacteria obtained from clinical sources.
Materials and Methods: Bacterial strains were procured from routine clinical samples. Bacterial biomass production was done in liquid media which was further harvested and lysed. The supernatent(E) in varying concentrations was then mixed with varying concentrations of 1mM AgNO3(M) (E:M ratio). Visual examination for colour change and confirmation by UV-Spectrophotometry (UV-S) was done and AgNPs were separated by Ultra-centrifugation. The synthesised NanoParticles(NPs) were characterized by Scanning Electron Microscopy(SEM) and X-Ray Diffraction(XRD) studies for confirmation.
Results: The UV-S showed an absorption value at 450nm as 1.3 in 1E:1M for Escherichia coli followed by Abs: 1.0 for Staphylococcus aureus in 1E:1M ratio. The Dynamic Light Scattering study showed that the particles obtained in the study were predominantly in the acceptable range of 127.35nm & 90.96nm for Staphylococcus aureus & Escherichia coli respectively. When observed under SEM, the synthesised particles were found to be agglomerated, but polydispersed and crystalline in nature. In XRD study a maximum peak was obtained at 38.22 which confirmed the crystalline structure synthesized from bacterial extract as AgNPs when compared with JCPD standards.
Introduction
Among several nanoparticles, attraction towards Silver Nanoparticles (AgNPs) is mainly because of its biocompatibility in therapeutics and also as antimicrobial agent biosensors, antibacterial agents, cancer treatment, gene therapy, and DNA analysis, enhancing reaction rates and magnetic resonance imaging.[4], [3], [2], [1] History of synthesis of nanoparticles dates back to when Klaus and co-workers have shown that the bacterium Pseudomonas stutzeri AG259, which was isolated in a silver mine, when placed in a concentrated aqueous silver nitrate solution, played a major role in the reduction of the Ag+ ions and the formation of Silver Nanoparticles (AgNPs) of a well-defined structure and distinct size and within the bacterial periplasmic space.[5]
Many bacteria, fungi, and plants have shown the ability to synthesize metallic nanoparticles and all have their own advantages and disadvantages. The use of microbes to synthesis nanoparticles is a very eco-friendly process and has enormous advantages over the other known physical and chemical processes since it takes place at ambient pressure and temperature.[6]
Saifuddin et al in 2009, demonstrated the extracellular synthesis of AgNPs (∼ 5–50 nm) using a cell-free extract of B. subtilis and microwave irradiation.[7] In 2007, Shahverdi et al reported the rapid green synthesis of AgNPs (within 5 mins) using the cell-free culture supernatants of gram Negative bacteria like Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae. [8]
In the studies, two strains of Bacillus subtilis (denoted T’1 and I’1a) were used. The biological synthesis of AgNPs was performed using supernatants obtained from cultures of bacteria growing on brewery effluents, molasses, and Luria–Bertani (LB) medium. [9]
The nanoparticles displayed free radical scavenging activities. This paper thus highlights nanoparticle synthesis by a hitherto unreported Actinomycetes culture, identifies the biomolecule involved in the process and describes the associated antioxidant activity. [10]
Hosseini-Abari et al, proposed a cost-effective and environmental-friendly biotechnological process for the synthesis of silver nanoparticles extracellularly using the bacterial spores.[11]
Furthermore, in 2009, the Susceptibility of MRSA, methicillin-resistant Staphylococcus epidermidis and Streptococcus pyogenes to AgNPs was demonstrated. [12]
Extracellular and intracellular synthesis of AgNPs using several bacterial strains like B. amyloliquefaciens, B. flexus, B. megaterium, and S. aureus has also been demonstrated.[15], [14], [13]
Interestingly, the antibacterial activity was seen to be exhibited by microbial GLP-capped AgNPs against V. cholerae comparable to ciprofloxacin. [16]
Few researchers also suggested the water-soluble fraction of the extracellular polysaccharides (EPS)/matrix of Nostoc commune is a potent capping agent and a reducing for the biosynthesis of AgNPs. Morsy FM et al, also suggested that AgNPS can be used as an effective surface sterilizing agent on seed crops against phytopathogenic fungi.[17] The multidrug-resistant organisms like P. aeruginosa and K. pneumonia were seen to be more susceptible to the AgNPs when compared to foodborne pathogen L. monocytogenes. Aspergillus spp. showed a maximum susceptibility compared to Penicillium spp. Researchers also suggested that exopolysaccharide-stabilized AgNPs can be used in various biomedical applications as antimicrobial agents.[18]
The nanocomposite material obtained by Liu C et al showed desirable activity in inhibiting both Gram-positive Staphylococcus aureus and Gram-negative Escherichia coli on an agar culture plate and also in liquid culture, showing the potential of the material to be used in wound dressings as an antimicrobial.[19]
Moreover, the synthesized AgNPs inhibited many medically important pathogenic bacteria like Bacillus subtilis, Enterococcus faecalis, Escherichia coli and Salmonella typhimurium and yeast-like Candida albicans.[1] Drug delivery systems which are Nano-scaled can be used efficiently into a porous 3D scaffold in grafts to enhance the tissue regeneration capacity. In conclusion, Nano-structured biomaterials are a very rapidly expanding research area and are providing newer enabling technologies in the field of regenerative medicine.[3]
To achieve the AgNPs with their unique properties, there is a pressing need to develop a cheaper and eco-friendly method for the synthesis of AgNPs which eliminates the use of toxic chemicals during their synthesis. In this pursuit, this study was taken up to study to find out the optimum parameters required to achieve silver nanoparticles using a cell-free extract of bacterial strains from clinical sources.
Materials and Methods
Bacterial biomass production
A Gram-Positive Bacteria (Staphylococcus aureus) & a Gram-Negative Bacteria (Escherichia coli) were obtained from clinical samples in pure form and were used for the production of the bacterial biomass. The isolated bacteria were inoculated in culture flasks with Luria Bertani Broth and incubated for 48 hours to give maximum yield. A media free culture of the bacteria was obtained by centrifuging at 5000rpm for 10mins followed by washing with distilled water. The media free bacteria obtained were kept in distilled water for 24hrs, to lyse the bacteria. This was then centrifuged at 12000 rpm for 15 minutes ([Figure 1]). The supernatant was then collected for further processes to synthesis nanoparticles.

Preparation of AgNO3 solution
Silver nitrate was chosen as the metal salt for the biosynthesis of AgNPs. AgNO3 (HiMedia). A volume of 500 ml of 1mM solution of silver nitrate required for the study was prepared using double distilled water and was stored in an amber-colored bottle.
Synthesis of AgNPs
Phase I
3 ratios were put up; 9:1(9ml supernatant and 1ml metal salt solution){9E:1M}, 1:1 (5ml supernatant and 5ml metal salt solution {1E:1M}), and 1:9 (1ml supernatant and 9ml metal salt solution) {1E:9M}, for each organism. The mixtures were left at room temperature to react. Hourly sub-samples were taken out of the reaction mixtures and were subjected to UV-visible Spectrophotometer analysis to fix the suitable reaction time and the appropriate ratio to obtain maximum AgNP production. After 24 hrs, the initial detection of AgNPs was carried out by proper visual observation of the characteristic colour change in the filtrate ([Figure 2]). The reacted samples after the colour change were subjected to UV spectrum analysis from 200-800 wavelengths at 1 nm resolution.



Phase II
From the UV spectra obtained for three reaction samples, the best out of the three ratios of metal salt to supernatant was selected and the synthesis was done for further studies. AgNP pellets were recovered by centrifuging (15,000 rpm) for 15 min. The residue settled at the bottom of the tubes are washed in distilled water repeatedly to remove any culture media. Further it was transferred to petri dish and dried at 60 and then in muffle furnace at 750oC to burn out all organic matter to get nanoparticles alone. Thus prepared nanoparticles are used for further characterization study.
Characterization
SEM is used for morphological characterization at the nm to mm scale. The dried powder of nanoparticles are viewed under SEM (Model JSM-6610LV.D). Images on surface morphology are obtained. For XRD analysis (Rigaku Ultima IV), the liquid phase nanoparticle solution was dried in an oven at 60°C and then in a muffle furnace at 750°C to form a powder. The dried powder was collected for characterization by an X’pert Pro x-ray diffractometer operating at 40 kV and a current of 30mA with Cu Ka radiation in θ-2θ configuration.
Antibiotic susceptibility testing
The dried powder of AgNPs thus generated were challenged with 0.5 Mc Farland standard of E.coli & Staphylococcus aureus in varying concentrations of 10µg, 20µg, 30µg, 40µg/ml, 50µg/ml, 60µg/ml, 70µg/ml, 80µg/ml, 90µg/ml & 100µg/ml in Muller Hilton agar broth. At periodic intervals of 4 hrs, and their absorbance was plotted.
Results
UV spectra
In the reaction tubes, reduction of silver nitrate in to silver has taken place in 6 hours exhibiting change of colour of the reaction solution to brown. Change of colour from milky white to brown is the characteristic indicator of formation of silver. Besides, the UV-Vis spectrum showed a peak at 460nm (normal range is 380-520nm). UV spectra are given as [Figure 4], [Figure 3]. Maximum absorption is shown in 1:3 (1E:1M) for Escherichia coli Abs: 1.0 at 450nm for Staphylococcus aureus in 1E:1M ratio, ([Table 1]). From this phase I study it is demonstrated that ratio of 1:1 of bacterial extract to 1mM AgNO3 solution is ascertained as the optimum ratio for synthesizing smaller nanoparticles. Hence, the same ratio is taken for phase-II and further synthesis and characterization.
Dynamic light scattering
Particle size obtained by DLS is tabulated in [Table 2] and shown in [Figure 6], [Figure 5] confirming the size of the Silver particle obtained in the study was predominantly in the acceptable range (90-120nm).


Scanning electron microscopy
The SEM image of AgNPs are given in [Figure 7]. The images revealed agglomeration of particles but polydispersed.

X-ray diffraction
The results are presented in[Figure 8] and 2 theta values are given in [Figure 9] showing the 2 theta values for the silver particles: 38.22, 44.45.64.56 and 77.50 and the braggs diffraction at 111,200,220 and 311 which closely matching with the international standard given by Joint Commission on Powder Diffraction standard (JCPD standard).

Antibiotic susceptibility testing
[Figure 10] show the anti-bactericidal activity of AgNPs against Escherichia coli & Staphylococcus aureus, with MIC of 30 µg/ml and 60 µg/ml respectively.

Organism/Ratio | 9E:1M | 1E:1 M | 1M:9E |
Staphylococcus aureus | W: 450nm A : 0.7 | W: 450nm A : 1.0 | W: 450nm A : 0.6 |
Escherichia coli | W: 450nm A : 0.7 | W: 460nm A : 1.3 | W: 450nm A : 0.6 |
Organism | Average |
Staphylococcus aureus | 127.35nm |
Escherichia coli | 90.96nm |

Discussion
AgNPs are reported to possess unique properties such as good conductivity, chemical stability, and catalytic properties than its bulk counterpart. These NPs also have antifungal, anti-viral and anti-inflammatory properties also.[20], [5] They showed effective antimicrobial activity against highly multi-resistant strains such as methicillin-resistant Staphylococcus aureus.[21] In view of such potency of AgNPs, in the recent past, they have made efforts to make use of microorganisms as possible eco-friendly nanofactories for the synthesis of silver nanoparticles.
The formation of silver NPs is mediated by the organic substances present in the cell free extract of the selected bacteria. The metal salt is reduced to metal i.e. silver nitrate is reduced to silver NPs. The formation of such particles is indicated by the change in the colour of the reaction solution to brown and this colour is the characteristics of silver nanoparticles.[22] The colour change takes place due to the Plasmon vibrations exhibited the nanoparticles formed in the solutions. Similar observation was also reported earlier in Bacillus megaterium, where a pale yellow to brown colour was formed due to the reduction of aqueous silver ions to silver nanoparticles.[15] This supports the fact that change in colour as observed in the experiment can be considered as an indication of silver nanoparticles formation. Further such inference is also confirmed by UV spectra recording a peak at 460nm (within the characteristic band range-380-520nm). Therefore, as reported 23 earlier, UV spectral studies is also could be an effective tool in nanoparticle studies.[23]
Optimisation of extract to metal salt is a crucial factor in standardising inputs. Moreover, as the synthesis involves chemical reactions, contraction of both reactants viz. cell free extract of given bacterium and the metal salts. Therefore, in the present study, the chemical reduction was more efficient in synthesising Nano sized particles at the ration of 1:1 for both bacterial extracts at 10 mMol silver nitrate concentration. The ratio has showed an average size of the particles as 85 nm.
The nature of chemical reduction or the mechanism behind metal reduction by extract and organic molecules involved in this reduction process, have been discussed widely without arriving any concrete explanation. However, presently it is explained that intracellular enzymes like nitrate reductase present in the microbes are responsible for the reduction of these metal ions to metal nanoparticles.[24] This was also reported in the bacteria Bacillus licheniformis, where this enzyme secreted by the bacterium was responsible for the reduction of Ag metal to metal nanoparticles.[25], [22] Spectroscopically analysed the organic compounds present in the cell free bacterial extract and suggested the strong interaction of aromatics, lipids, amino acids as well as ketones. Besides, various bacteria are reported to possess a variety of bio agents that reduce metal salt to metal nanoparticles such as Rhamnolipids in Pseudomonas aeruginosa;[27], [26] URAK –a fibrinolytic enzyme in Bacillus cereus.[27] Cellulose in Gluconacetobacter with Cellulose [28]- Actinorhodin pigment In Streptomyces coelicolor; [29] Flagellin in Salmonella typhimurium[30] - Presence and binding of protein, carbohydrates and aromatics and fatty acids with AgNPs might have behaved as reducing agent. Biomolecules like proteins, bio-surfactants and enzymes, present in the microorganisms act as reducing agents. Also, in many bacterial strains, bio-surfactants can be used as stabilizing agents or capping agents.[31]
Extracellular synthesis of AgNPs happens by of the trammelling of metal ions on the outer surface of the microbial cells and in the presence of the enzymes or biomolecules they are reduced, while intracellular synthesis happens inside the microbial cells. Researchers also suggested that the extracellular synthesis of nanoparticles favours large-scale, is cheap, and requires simpler downstream processing and production. Hence the synthesis of AgNPs extracellularly is preferred,[24] when compared to intra-cellular method[32] as it involves more of fine chemicals and processing techniques.
The exact mechanisms of toxicity activity and antimicrobial activity by AgNPs are a still unclear subject matter among biotechnologists and microbiologists world-wide. However, quoting the biophysical properties of them in general, the mechanism might could be because of more than one cellular kinetics. There are reports indicating, the electrostatic attraction between AgNPS which are positively charged and bacterial cells which are negatively charged.[32] Other probable mechanisms involve interaction between biological macromolecules such as enzymes and DNA and silver molecules through an electron-release mechanism[33] or a probable free radical production.[34] Both silver ions and AgNPs can actually work by changing the three dimensional structure of proteins by altering the disulphide bonds and by blocking the functional operations of the microbes.[37], [36], [35] Park et al proposed that the inhibition of protein synthesis and cell wall synthesis has been also been caused by AgNPs.[38] The growth of microbes is inhibited by the nanoparticles which modulated the phosphotyrosine profile of the bacterial peptide affects signal transduction.[39]
Therefore, from the results obtained from the current microbial assay, it could be reported that AgNPs are more potent in treating diseases caused by Gram positive bacteria rather than Gram negative bacteria. It is to be noted that besides such wide range of research undertaken globally to find the ways and means of utilizing the AgNPs in the field of medicine and diagnostic, an attempt was also made and reported that AgNPs are preliminarily found to possess ability to suppress cancer cell proliferation.[40] Therefore, it is hopefully conceived that AgNPs can be used as a magic Nano robot that could be employed search and kill the target cell and/or pick and place the drug in the specified site precisely.
Acknowledgements
I record my sincere gratitude to my dad, for always being there for me, guiding me and helping me in completing this study.
Source of Funding
None.
Conflict of Interest
None.
References
- Sadhasivam S, Shanmugam P, Yun K. Biosynthesis of silver nanoparticles by Streptomyces hygroscopicus and antimicrobial activity against medically important pathogenic microorganisms. Colloids and Surfaces B: Biointerfaces. 2010;81(1):358-62. [Google Scholar]
- Shrivastava S, Dash D. Applying Nanotechnology to Human Health: Revolution in Biomedical Sciences. J Nanotechnol. 2009;2009:1-14. [Google Scholar]
- Wei G, Ma PX. Nanostructured Biomaterials for Regeneration. Adv Funct Mater. 2008;18(22):3568-82. [Google Scholar]
- Liu J, Zhao Y, Guo Q, Wang Z, Wang H, Yang Y, et al. TAT-modified nanosilver for combating multidrug-resistant cancer. Biomaterials. 2012;33(26):6155-6161. [Google Scholar] [Crossref]
- Klaus T, Joerger R, Olsson E, Granqvist C. Silver-based crystalline nanoparticles, microbially fabricated. Proc Natl Acad Sci. 1999;96(24):13611-4. [Google Scholar]
- Mukherjee P, Roy M, Mandal BP, Dey GK, Mukherjee PK, Ghatak J. Green synthesis of highly stabilized nanocrystalline silver particles by a non-pathogenic and agriculturally important fungus T. asperellum. Nanotechnol. 2008;19(7). [Google Scholar]
- Saifuddin N, Wong CW, Yasumira AAN. Rapid Biosynthesis of Silver Nanoparticles Using Culture Supernatant of Bacteria with Microwave Irradiation. E-J Chem. 2009;6(1):61-70. [Google Scholar]
- Shahverdi AR, Fakhimi A, Shahverdi HR, Minaian S. Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli Nanomedicine. Nanotechnol, Biol Med. 2007;3(2):168-71. [Google Scholar]
- Mendrek B, Chojniak J, Libera M, Trzebicka B, Bernat P, Paraszkiewicz K. Silver nanoparticles formed in bio- and chemical syntheses with biosurfactant as the stabilizing agent. J Dispersion Sci Technol. 2017;38(11):1647-55. [Google Scholar]
- Sowani H, Mohite P, Munot H, Shouche Y, Bapat T, Kumar AR. Green synthesis of gold and silver nanoparticles by an actinomycete Gordonia amicalis HS-11: Mechanistic aspects and biological application. Process Biochemis. 2016;51(3):374-83. [Google Scholar]
- Hosseini-Abari A, Emtiazi G, Ghasemi SM. Development of an eco-friendly approach for biogenesis of silver nanoparticles using spores of Bacillus athrophaeus. World J Microbiol Biotechnol. 2013;29(12):2359-64. [Google Scholar]
- Nanda A, Saravanan M. Biosynthesis of silver nanoparticles from Staphylococcus aureus and its antimicrobial activity against MRSA and MRSE. Nanomedicine. 2009;5(4):452-6. [Google Scholar]
- Wei X, Luo M, Li W, Yang L, Liang X, Xu L. Synthesis of silver nanoparticles by solar irradiation of cell-free Bacillus amyloliquefaciens extracts and AgNO3. Bioresour Technol. 2012;103:273-8. [Google Scholar]
- Priyadarshini S, Gopinath V, Priyadharsshini NM, Ali DM, Velusamy P. Synthesis of anisotropic silver nanoparticles using novel strain, Bacillus flexus and its biomedical application. Coll Surf B Biointerface. 2013;102:232-7. [Google Scholar]
- Saravanan M, Vemu AK, Barik SK. Rapid biosynthesis of silver nanoparticles from Bacillus megaterium (NCIM 2326) and their antibacterial activity on multi drug resistant clinical pathogens. Coll Surf B. 2011;88(1):325-31. [Google Scholar]
- Gahlawat G, Shikha S, Chaddha BS, Chaudhuri SR, Mayilraj S, Choudhury AR. Microbial glycolipoprotein-capped silver nanoparticles as emerging antibacterial agents against cholera. Micro Cell Fact. 2016;15(1). [Google Scholar]
- Morsy FM, Nafady NA, Abd-Alla MH, Elhady DA. Green synthesis of silver nanoparticles by water soluble fraction of the extracellular polysaccharides/matrix of the cyanobacterium Nostoc commune and its application as a potent fungal surface sterilizing agent of seed crops. Univ J Microbiol Res. 2014;2:36-43. [Google Scholar]
- Kanmani P, Lim ST. Synthesis and structural characterization of silver nanoparticles using bacterial exopolysaccharide and its antimicrobial activity against food and multidrug resistant pathogens. Process Biochem. 2013;48(7):1099-106. [Google Scholar]
- Liu C, Yang D, Wang Y, Shi J, Jiang Z. Fabrication of antimicrobial bacterial cellulose-Ag/AgCl nanocomposite using bacteria as versatile biofactory. J Nanopart Res. 2012;14:1084-95. [Google Scholar]
- Ahmad A, Mukherjee P, Senapati S, Mandal D, Khan M, Kumar R. Extracellular biosynthesis of silver nanoparticles using the fungus Fusarium oxysporum. Colloids and Surfaces B: Biointerfaces. 2003;28(4):313-8. [Google Scholar]
- Pan´aˇcek A, Kv´ıtek L, Prucek R. Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. J Phys Chem B. 2006;110(33):16248-53. [Google Scholar]
- Kalimuthu K, Babu RS, Venkataraman D, Bilal M, Gurunathan S. Biosynthesis of silver nanocrystals by Bacillus licheniformis. Colloids and Surfaces B: Biointerfaces. 2008;65(1):150-3. [Google Scholar]
- Sastry M, Patil V, Sainkar SR. Electrostatically Controlled Diffusion of Carboxylic Acid Derivatized Silver Colloidal Particles in Thermally Evaporated Fatty Amine Films. J Phys Chem B. 1998;102(8):1404-10. [Google Scholar]
- Durán N, Priscyla D, Marcato PD, Alves O, Souza GD, Esposito E. Mechanistic aspects of biosynthesis of silver nanoparticles by several Fusarium oxysporum strains. J Nanobiotechnol. 2005;3:1-7. [Google Scholar]
- Jeevan P, Ramya K, Rena AE. Extracellular biosynthesis of silver nanoparticles by culture supernatant of Pseudomonas aeruginosa. Indian J Biotechnol. 2012;11:72-6. [Google Scholar]
- Kumar CG, Mamidyala SK, Das B, Sridhar B, Devi GS, Karuna MS. Synthesis of biosurfactant-based silver nanoparticles with purified rhamnolipids isolated from Pseudomonas aeruginosa BS-161R. J Microbiol Biotechnol. 2010;20:1061-9. [Google Scholar]
- Deepak V, Umamaheshwaran PS, Guhan K, Nanthini RA, Krithiga B, Jaithoon NMH. Synthesis of gold and silver nanoparticles using purified URAK. Colloids and Surfaces B: Biointerfaces. 2011;86(2):353-8. [Google Scholar]
- Liu C, Yang D, Wang Y, Shi J, Jiang Z. Fabrication of antimicrobial bacterial cellulose-Ag/AgCl nanocomposite using bacteria as versatile biofactory. J Nanopart Res. 2012;14:1084-95. [Google Scholar]
- Manikprabhu D, Lingappa K. Antibacterial activity of silver nanoparticles against methicillin-resistant Staphylococcus aureus synthesized using model Streptomyces sp. pigment by photo-irradiation method. J Pharm Res. 2013;6(2):255-60. [Google Scholar]
- Gopinathan P, Ashok AM, Selvakumar R. Bacterial flagella as biotemplate for the synthesis of silver nanoparticle impregnated bionanomaterial. Appl Surface Sci. 2013;276:717-22. [Google Scholar]
- Siddiqi KS, Husen A, Rao RAK. A review on biosynthesis of silver nanoparticles and their biocidal properties. J Nanobiotechnol. 2018;16(1). [Google Scholar]
- Cao YW, Jin R, Mirkin CA. DNA-Modified Core−Shell Ag/Au Nanoparticles. J Am Chem Soc. 2001;123(32):7961-2. [Google Scholar]
- Sharma VK, Yngard RA, Lin Y. Silver nanoparticles: Green synthesis and their antimicrobial activities. Adv Colloid Interface Sci. 2009;145(1-2):83-96. [Google Scholar]
- Ankanna S, Prasad T, Elumalai EK, Savithramma N. Production of biogenic silver nanoparticles using Boswelliaovalifoliolata stem bark. Dig J Nanomater Biostruct. 2010;5:369-72. [Google Scholar]
- Sadeghi B, Gholamhoseinpoor F. A study on the stability and green synthesis of silver nanoparticles using Ziziphora tenuior (Zt) extract at room temperature. Spectrochim Acta Part A: Mol Biomol Spectrosc . 2015;134:310-5. [Google Scholar]
- Jia X, Ma X, Wei D, Dong J, Qian W. Direct formation of silver nanoparticles in cuttlebone-derived organic matrix for catalytic applications. Colloids and Surfaces A: Physicochem Eng Aspects. 2008;330(2-3):234-40. [Google Scholar]
- Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol Adv. 2009;27(1):76-83. [Google Scholar]
- Park J, Lim DH, Lim HJ, Kwon T, Choi JS, Jeong S. Size dependent macrophage responses and toxicological effects of Ag nanoparticles. Chem Commun. 2011;47:4382-6. [Google Scholar]
- Ahmed S, Ahmad M, Swami BL, Ikram S. A review on plants extract mediated synthesis of silver nanoparticles for antimicrobial applications: A green expertise. J Adv Res. 2016;7(1):17-28. [Google Scholar]
- Kathiravan V, Ravi S, Ashokkumar S. Synthesis of silver nanoparticles from Melia dubia leaf extract and their in vitro anticancer activity. Spectrochimica Acta Part A: Mol Biomol Spectrosc. 2014;130:116-21. [Google Scholar]
- Abstract
- Introduction
- Materials and Methods
- Bacterial biomass production
- Preparation of AgNO3 solution
- Synthesis of AgNPs
- Characterization
- Antibiotic susceptibility testing
- Results
- UV spectra
- Dynamic light scattering
- Scanning electron microscopy
- X-ray diffraction
- Antibiotic susceptibility testing
- Discussion
- Acknowledgements
- Source of Funding
- Conflict of Interest
- References
How to Cite This Article
Vancouver
Y V. Optimisation of reactant concentration in Biosynthesis of Silver nanoparticles using pathogenic bacteria isolated from clinical sources and their characterisation [Internet]. Indian J Microbiol Res. 2020 [cited 2025 Sep 23];7(1):63-69. Available from: https://doi.org/10.18231/j.ijmr.2020.014
APA
Y, V. (2020). Optimisation of reactant concentration in Biosynthesis of Silver nanoparticles using pathogenic bacteria isolated from clinical sources and their characterisation. Indian J Microbiol Res, 7(1), 63-69. https://doi.org/10.18231/j.ijmr.2020.014
MLA
Y, Valentina. "Optimisation of reactant concentration in Biosynthesis of Silver nanoparticles using pathogenic bacteria isolated from clinical sources and their characterisation." Indian J Microbiol Res, vol. 7, no. 1, 2020, pp. 63-69. https://doi.org/10.18231/j.ijmr.2020.014
Chicago
Y, V.. "Optimisation of reactant concentration in Biosynthesis of Silver nanoparticles using pathogenic bacteria isolated from clinical sources and their characterisation." Indian J Microbiol Res 7, no. 1 (2020): 63-69. https://doi.org/10.18231/j.ijmr.2020.014